Gonadotropin releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (HCG) for triggering of ovulation in ovarian stimulation cycles in polycystic ovarian syndrome (PCOS) women
Dorra, A., Ismail, H., Abdelhafez, M., Samir, K., ElMenayer, A. (2024). Gonadotropin releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (HCG) for triggering of ovulation in ovarian stimulation cycles in polycystic ovarian syndrome (PCOS) women. EKB Journal Management System, 28(1), 28-38. doi: 10.21608/egyfs.2024.345927
Ammar Hesham Dorra; Hamed Youssef Ismail; Mohamed Sayed Abdelhafez; Khaled Samir; Ahmed Mousa ElMenayer. "Gonadotropin releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (HCG) for triggering of ovulation in ovarian stimulation cycles in polycystic ovarian syndrome (PCOS) women". EKB Journal Management System, 28, 1, 2024, 28-38. doi: 10.21608/egyfs.2024.345927
Dorra, A., Ismail, H., Abdelhafez, M., Samir, K., ElMenayer, A. (2024). 'Gonadotropin releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (HCG) for triggering of ovulation in ovarian stimulation cycles in polycystic ovarian syndrome (PCOS) women', EKB Journal Management System, 28(1), pp. 28-38. doi: 10.21608/egyfs.2024.345927
Dorra, A., Ismail, H., Abdelhafez, M., Samir, K., ElMenayer, A. Gonadotropin releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (HCG) for triggering of ovulation in ovarian stimulation cycles in polycystic ovarian syndrome (PCOS) women. EKB Journal Management System, 2024; 28(1): 28-38. doi: 10.21608/egyfs.2024.345927

Gonadotropin releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (HCG) for triggering of ovulation in ovarian stimulation cycles in polycystic ovarian syndrome (PCOS) women

The Egyptian Journal of Fertility of Sterility
Article 5, Volume 28, Issue 1 - Serial Number 11106352, January 2024, Page 28-38  XML PDF (4.37 MB)
Document Type: Original Article
DOI: 10.21608/egyfs.2024.345927
View on SCiNiTO View on SCiNiTO
Authors
Ammar Hesham Dorra email 1; Hamed Youssef Ismail2; Mohamed Sayed Abdelhafez2; Khaled Samir2; Ahmed Mousa ElMenayer2
1Department of Obstetrics and Gynecology, Faculty of Medicine, Mansoura, Egypt
2Department of Obstetrics and Gynecology, Mansoura University, Mansoura, Egypt
Abstract
Objective: To assess the efficacy and safety of gonadotropin releasing hormone agonist (GnRHa) as an alternative to conventional human chorionic gonadotropin (HCG) for triggering of ovulation in patients with polycystic ovarian syndrome (PCOS) undergoing sequential minimal ovarian stimulation followed timed intercourse.
Methods: A randomized controlled study that was conducted on PCOS patients subjected to sequential minimal ovarian stimulation followed by timed intercourse. All participants were randomly allocated at time of triggering of ovulation into 2 groups; GnRHa group in which ovulation was triggered by single SC injection of 0.2 mg of triptorelin, and HCG group in which ovulation was triggered by single IM injection of 5000 IU of urinary HCG. The main study’s outcome measures included ovulation rate, clinical pregnancy rate and incidence of early ovarian hyperstimulation syndrome (OHSS).
Results: Final analysis was performed for data of 47 participants in the GnRHa group and 46 participants in the HCG group. There was no significant difference between the GnRHa and the HCG groups in the ovulation rate (95.7% vs 93.5%; P = 0.628) and clinical pregnancy rate (23.4% vs 21.7%; P = 0.848). There was no cases of OHSS in the GnRHa group and just one case in the HCG group, with no significant difference in the incidence of OHSS between the 2 groups (P = 0.495).
Conclusion: The GnRHa could be an effective and safe alternative to the traditional HCG in ovulation triggering after sequential minimal ovarian stimulation in PCOS patients without affecting ovulation and clinical pregnancy rates.



Keywords
Keywords: PCOS; GnRHa; HCG; OHSS
Statistics
Article View: 27
PDF Download: 25